Blog Posts

How Changes To The Declaration Of Helsinki Impact Clinical Trials

By Jessica Cordes - November 18, 2024

Guest Column | October 08, 2024 An Expert Guide To Effective Sponsor Oversight In Clinical Trials By Jessica Cordes, senior consultant, Clinical Excellence GmbH Sponsor oversight and risk management play vital roles in maintaining data reliability, patient safety, and the

Clinical Leader

An Expert Guide To Effective Sponsor Oversight In Clinical Trials

Clinical Leader

Extended GCP Training Is A “Must” For Cell And Gene Therapy Clinical Trials

Clinical Leader

These 3 Areas Need Risk Management Attention Now

Clinical Leader

Umbrella? Basket? Discover 4 Types of Adaptive Clinical Trials And Their Benefits

Clinical Leader

How To Determine Country Feasibility For Cell And Gene Therapy Clinical Trials

Clinical Leader

Site Feasibility Tips For Cell And Gene Therapy Clinical Trials

I'm Jessica Cordes

I am a professional in Clinical Operations dedicated to helping you as a small Company

to conduct successful First-In-Human Clinical Trials and develop your Organization to abhiebe your Drug Development Goals.

With a Master's degree in Molecular Life Science and over 15 years of experience in Clinical Trials, whereas over 12 years in Oncology and

over 6 years in Cell and Gene Therapy, I have honed my skills in areas such as

Protocol Design, Site Selection and Site Feasibility, Patient Recruitment, as well as

Organizational Development and Leadership.

How Changes To The Declaration Of Helsinki Impact Clinical Trials

18.11.2024

Clinical Leader

An Expert Guide To Effective Sponsor Oversight In Clinical Trials

08.10.2024

Let's Connect

Book a Meeting

Elevate Your Clinical Excellence!

Unlock the power of spotlighted information delivery

via my bi-weekly newsletter Clinical Operations Spotlight